Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.60 |
| ▸ | CRHBP | P24387 | 1/20 | 0.59 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.58 |
| ▸ | MGLL | Q99685 | 1/20 | 0.57 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | DRD2 | P14416 | 1/20 | 0.55 |
| ▸ | DRD4 | P21917 | 1/20 | 0.55 |
| ▸ | DRD3 | P35462 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9308071 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL9232088 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL5052431 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL3332201 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL1963497 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL51004 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL8410318 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL5387345 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL1240044 | 0.98 | MAPT (0.63) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL25232552 | 0.95 | MAPT (0.65) | MAPTL3MBTL1NPC1RAB9AHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101298419-B | Preparation of 3-ethoxy-4-decyloxy nitrobenzene | ZHEJIANG GENEBEST PHARMACEUTICAL CO LTD | 2010-05-12 | — | — | CN | claimed |
| CN-101298419-A | Preparation of 3-ethoxy-4-decyloxy nitrobenzene | FUYANG GENEBEST CHEMICAL INDUS (CN) | 2008-11-05 | — | — | CN | claimed |
| CN-115290736-A | Improved magnesium ion selective membranes | 西门子医疗保健诊断公司 | 2022-11-04 | — | — | CN | disclosed |
| CN-107209142-B | Improved magnesium ion selective membranes | 西门子医疗保健诊断公司 | 2022-09-13 | — | — | CN | disclosed |
| US-20120232150-A1 | PHTHALANILATE COMPOUNDS AND METHODS OF USE | University of Nortre Dame du Lac | 2012-09-13 | — | — | US | disclosed |
| WO-2011026107-A1 | PHTHALANILATE COMPOUNDS AND METHODS OF USE | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2011-03-03 | — | — | WO | disclosed |
| CN-101298419-B | Preparation of 3-ethoxy-4-decyloxy nitrobenzene | ZHEJIANG GENEBEST PHARMACEUTICAL CO LTD | 2010-05-12 | — | — | CN | disclosed |
| CN-101298419-A | Preparation of 3-ethoxy-4-decyloxy nitrobenzene | FUYANG GENEBEST CHEMICAL INDUS (CN) | 2008-11-05 | — | — | CN | disclosed |
| US-7365359-B2 | Organic semiconductor material and organic semiconductor element | DAI NIPPON PRINTING CO., LTD. (JP) | 2008-04-29 | — | — | US | disclosed |
| US-7282245-B2 | Device with multiple liquid crystal layers | XEROX CORPORATION (US) | 2007-10-16 | — | — | US | disclosed |
| US-7211301-B2 | Liquid crystal compositions including non-dipolar monomer | XEROX CORPORATION (US) | 2007-05-01 | — | — | US | disclosed |
| US-20040201011-A1 | Organic semiconductor material and organic semiconductor element | DAI NIPPON PRINTING CO., LTD. (JP) | 2004-10-14 | — | — | US | disclosed |
| US-6096217-A | Supported liquid membrane separation | LOCKHEED MARTIN ENERGY RESEARCH CORPORATION (US) | 2000-08-01 | — | — | US | disclosed |
| US-6086769-A | Supported liquid membrane separation | COMMODORE SEPARATION TECHNOLOGIES, INC. (US) | 2000-07-11 | — | — | US | disclosed |
| WO-1998010852-A1 | SUPPORTED LIQUID MEMBRANE SEPARATION | COMMODORE SEPARATION TECHNOLOGIES, INC. (US) | 1998-03-19 | — | — | WO | disclosed |
| EP-0110299-A2 | Smectic liquid crystal compounds and liquid crystal compositions | HITACHI, LTD. (JP) | 1984-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120232150-A1 | PHTHALANILATE COMPOUNDS AND METHODS OF USE | MPO, ALPI, NQO1 | MAPT 2792/4885L3MBTL1 3370/4885NPC1 2813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.